<DOC>
	<DOC>NCT02008461</DOC>
	<brief_summary>The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were assessed with the use of an implanted monitoring device (IMD).</brief_summary>
	<brief_title>Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>atrial flutter, AV nodal reentry tachycardia, focal atrial tachycardia, WPW syndrome secondary atrial fibrillation congestive heart failure LV ejection fraction &lt; 35% left atrial diameter &gt; 60 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>